Becton Dickinson and Company (BDX) 113.16 $BDX
Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018
M2 - Wed Apr 16, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qkddr/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market by product type and drug delivery type, has witnessed a significant growth in the past few years and this growth is estimated to persist in the coming years. The primary pharmaceutical packaging products constitute majority of the market globally. While plastic bottles, blister packs, caps & closures, labels & accessories contribute largely to the pharmaceutical packaging market; pre-fillable syringes, inhalers, medication tubes, and other new products will drive the future growth in the industry. North America, Western Europe and Japan dominated the pharmaceutical packaging market in 2012 and accounted for over 70% of the market. These developed regions dominate the packaging market due their mature markets which consist of health conscious and high-spending population. On the other hand, Asia-Pacific is expected to overtake the North American & European pharmaceutical packaging markets on account of its fastest-double digit growth rate by 2018. The market in this region is spurred by the large economies of Japan, China, and India that are experiencing increased contract manufacturing activities, growth of pharmaceutical sector, increased government investment in healthcare facilities, and ageing population. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insight - Market Dynamics - Pharmaceutical Packaging Market, By Packaging Type - Pharmaceutical Packaging Market, By Packaging Material - Pharmaceutical Packaging Market, By Drug Delivery Type - Pharmaceutical Packaging Market, By Geography - Packaging Market For Veterinary Vaccines - Competitive Landscape - Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/3q...maceutical
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
2.5 Reasons to Hold On to Becton, Dickinson's Stock
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 14, 7:11PM CDT
Becton, Dickinson is a selection for the real-money Inflation-Protected Income Growth portfolio . In this brief video, portfolio manager Chuck Saletta offers two-and-a-half reasons he's holding on to Becton, Dickinson's stock despite its 31%...
This Is the Toughest Part of Investing
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 14, 8:14AM CDT
This past week was a tough one for the overall market and the real-money Inflation-Protected Income Growth portfolio . The iPIG portfolio lost more than $1,150 in market price since last week's update , as the S&P 500 dropped about 2.6% in that...
5 Rocket Stocks for a Tumbling Market
at The Street - Mon Apr 14, 8:09AM CDT
These stocks have both short-term gain catalysts and longer-term growth potential.
Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 1.46% Sell Off
Comtex SmarTrend(R) - Tue Apr 08, 4:56PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $113.47 to a high of $115.51. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $115.13 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Appointments, Positive Data Results, and New Product Innovations - Analyst Notes on Thermo Fisher Scientific, Boston Scientific, BD, DENTSPLY, and CareFusion
PR Newswire - Tue Apr 08, 1:09AM CDT
Today, Analysts Review released its analysts' notes regarding Thermo Fisher Scientific Inc. (NYSE: TMO), Boston Scientific Corporation (NYSE: BSX), Becton, Dickinson and Co. (NYSE: BDX), DENTSPLY International Inc. (NASDAQ: XRAY), and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
This Dividend Portfolio Continues to Dominate
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 07, 8:47AM CDT
The real-money Inflation-Protected Income Growth portfolio launched 16 months ago as of last Friday's market close. The portfolio's primary objective is to generate an income stream that rises at least as quickly as inflation. As detailed in last...
Cardinal Health to Acquire AccessClosure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 1:50PM CDT
Following the announcement, shares of Cardinal Health escalated 1.5% to close at $71.31 yesterday.
Balanced Risk-Reward for Covidien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:40PM CDT
We are impressed with the Covidien's recent fiscal 2014 first quarter results but remains concerned about stiff competition
Technical Roundup on Health Care Sector Stocks -- Research on Becton Dickinson and Co., Antares Pharma, Hooper Holmes, and Catamaran
PR Newswire - Thu Apr 03, 7:28AM CDT
On Wednesday, April 02, 2014, the NASDAQ Composite finished at 4,276.46, up 0.20%. The Dow Jones Industrial Average closed the session at 16,573.00, up 0.24% and the S&P 500 ended the day at 1,890.90, higher by 0.29%. The gains were broad based with eight out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 684.15, up 0.36%, and the index has gained 7.11% in the previous three months. Investor-Edge has initiated coverage on the following equities: Becton Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), Hooper Holmes Inc. (NYSE MKT: HH) and Catamaran Corp. (NASDAQ: CTRX). Free technical research on BDX, ATRS, HH and CTRX can be downloaded upon signing up at:
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
PR Newswire - Thu Apr 03, 7:00AM CDT
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.
CR Bard Touches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:10AM CDT
BCR's share price has recorded a healthy return of around 50% over a year's time.
Becton, Dickinson Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:10AM CDT
Becton Dickinson's share price has recorded a healthy return of around 25% over a year.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Hospital Study Identifies Syringe Plunger Contamination as Major Route of Exposure to Hazardous Drugs
PR Newswire - Wed Mar 26, 7:00AM CDT
ï"
Is J&J's Forgotten Half About to Take Off?
Peter Stephens, The Motley Fool - Motley Fool - Tue Mar 25, 5:30PM CDT
Johnson & Johnson is often cited as the biggest pharmaceutical company in the world, but it also generates a significant amount of revenue from medical device products. Let's take a deep dive into this division and focus on the key areas that...
Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018
M2 - Wed Apr 16, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qkddr/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market by product type and drug delivery type, has witnessed a significant growth in the past few years and this growth is estimated to persist in the coming years. The primary pharmaceutical packaging products constitute majority of the market globally. While plastic bottles, blister packs, caps & closures, labels & accessories contribute largely to the pharmaceutical packaging market; pre-fillable syringes, inhalers, medication tubes, and other new products will drive the future growth in the industry. North America, Western Europe and Japan dominated the pharmaceutical packaging market in 2012 and accounted for over 70% of the market. These developed regions dominate the packaging market due their mature markets which consist of health conscious and high-spending population. On the other hand, Asia-Pacific is expected to overtake the North American & European pharmaceutical packaging markets on account of its fastest-double digit growth rate by 2018. The market in this region is spurred by the large economies of Japan, China, and India that are experiencing increased contract manufacturing activities, growth of pharmaceutical sector, increased government investment in healthcare facilities, and ageing population. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insight - Market Dynamics - Pharmaceutical Packaging Market, By Packaging Type - Pharmaceutical Packaging Market, By Packaging Material - Pharmaceutical Packaging Market, By Drug Delivery Type - Pharmaceutical Packaging Market, By Geography - Packaging Market For Veterinary Vaccines - Competitive Landscape - Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/3q...maceutical
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
2.5 Reasons to Hold On to Becton, Dickinson's Stock
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 14, 7:11PM CDT
Becton, Dickinson is a selection for the real-money Inflation-Protected Income Growth portfolio . In this brief video, portfolio manager Chuck Saletta offers two-and-a-half reasons he's holding on to Becton, Dickinson's stock despite its 31%...
This Is the Toughest Part of Investing
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 14, 8:14AM CDT
This past week was a tough one for the overall market and the real-money Inflation-Protected Income Growth portfolio . The iPIG portfolio lost more than $1,150 in market price since last week's update , as the S&P 500 dropped about 2.6% in that...
5 Rocket Stocks for a Tumbling Market
at The Street - Mon Apr 14, 8:09AM CDT
These stocks have both short-term gain catalysts and longer-term growth potential.
Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 1.46% Sell Off
Comtex SmarTrend(R) - Tue Apr 08, 4:56PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $113.47 to a high of $115.51. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $115.13 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Appointments, Positive Data Results, and New Product Innovations - Analyst Notes on Thermo Fisher Scientific, Boston Scientific, BD, DENTSPLY, and CareFusion
PR Newswire - Tue Apr 08, 1:09AM CDT
Today, Analysts Review released its analysts' notes regarding Thermo Fisher Scientific Inc. (NYSE: TMO), Boston Scientific Corporation (NYSE: BSX), Becton, Dickinson and Co. (NYSE: BDX), DENTSPLY International Inc. (NASDAQ: XRAY), and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
This Dividend Portfolio Continues to Dominate
Chuck Saletta, The Motley Fool - Motley Fool - Mon Apr 07, 8:47AM CDT
The real-money Inflation-Protected Income Growth portfolio launched 16 months ago as of last Friday's market close. The portfolio's primary objective is to generate an income stream that rises at least as quickly as inflation. As detailed in last...
Cardinal Health to Acquire AccessClosure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 1:50PM CDT
Following the announcement, shares of Cardinal Health escalated 1.5% to close at $71.31 yesterday.
Balanced Risk-Reward for Covidien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:40PM CDT
We are impressed with the Covidien's recent fiscal 2014 first quarter results but remains concerned about stiff competition
Technical Roundup on Health Care Sector Stocks -- Research on Becton Dickinson and Co., Antares Pharma, Hooper Holmes, and Catamaran
PR Newswire - Thu Apr 03, 7:28AM CDT
On Wednesday, April 02, 2014, the NASDAQ Composite finished at 4,276.46, up 0.20%. The Dow Jones Industrial Average closed the session at 16,573.00, up 0.24% and the S&P 500 ended the day at 1,890.90, higher by 0.29%. The gains were broad based with eight out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 684.15, up 0.36%, and the index has gained 7.11% in the previous three months. Investor-Edge has initiated coverage on the following equities: Becton Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), Hooper Holmes Inc. (NYSE MKT: HH) and Catamaran Corp. (NASDAQ: CTRX). Free technical research on BDX, ATRS, HH and CTRX can be downloaded upon signing up at:
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
PR Newswire - Thu Apr 03, 7:00AM CDT
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.
CR Bard Touches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:10AM CDT
BCR's share price has recorded a healthy return of around 50% over a year's time.
Becton, Dickinson Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:10AM CDT
Becton Dickinson's share price has recorded a healthy return of around 25% over a year.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Hospital Study Identifies Syringe Plunger Contamination as Major Route of Exposure to Hazardous Drugs
PR Newswire - Wed Mar 26, 7:00AM CDT
ï"
Is J&J's Forgotten Half About to Take Off?
Peter Stephens, The Motley Fool - Motley Fool - Tue Mar 25, 5:30PM CDT
Johnson & Johnson is often cited as the biggest pharmaceutical company in the world, but it also generates a significant amount of revenue from medical device products. Let's take a deep dive into this division and focus on the key areas that...
